Advanced Drug Delivery Systems Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Advanced Drug Delivery Systems Market to 2027 - Global Analysis and Forecasts By Delivery Type (Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, and Parental Drug Delivery), Carrier Type (Liposomes, Nanoparticles, Microspheres, Monoclonal Antibodies, and Others); End User (Hospitals, Specialized Clinics, and Others) and Geography

Report Code: TIPMD00002604 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Advanced drug delivery systems refers to the improved methods for delivering the drug molecule to the desired site of the body for drug release and absorption. The goal of the advanced drug delivery system is to improve the provision of the therapeutic drug at the target site maintaining the desired drug concentration. Choosing a proper delivery route helps to achieve efficacious delivery for drugs that are available in various dosage forms.

Development of new drug and biologics formulation and advantages offered by advanced drug systems over conventional ones are anticipated to drive the growth of advanced drug delivery systems market during the forecast period. However, high pricing of advanced drug delivery systems and technological glitches in the development methods are expected to refrain the market growth to a certain extent.

The "Global Advanced Drug Delivery Systems Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by delivery type, carrier type, end user, and geography. The global advanced drug delivery systems market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global advanced drug delivery systems market is segmented on the basis of delivery type, carrier type and end user. On the basis of delivery type, the advanced drug delivery systems market is segmented into oral drug delivery, pulmonary drug delivery, transdermal drug delivery, and parental drug delivery. Based on carrier type, the advanced drug delivery systems market is segmented into liposomes, nanoparticles, microspheres, monoclonal antibodies, and others. The market is classified based on end user as, hospitals, specialized clinics, and others.

The advanced drug delivery systems market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global advanced drug delivery systems market based on delivery type, carrier type and end user. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The advanced drug delivery systems market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the advanced drug delivery systems market in the coming years, owing to follow up of advanced treatment approaches within healthcare industry and high adoption of advanced health solutions. Asia Pacific is expected to witness significant growth during the forecast period, which attributes to the improving healthcare infrastructure through significant investments.

The advanced drug delivery systems market report analyzes factors affecting advanced drug delivery systems market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the advanced drug delivery systems market in these regions.

The report also includes the profiles of key advanced drug delivery systems manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the advanced drug delivery systems market include, Johnson & Johnson Services, Inc., 3M, Abbott, Baxter, Allergan, AstraZeneca, Genentech, Inc., Novartis AG, Pfizer, Inc., and Takeda Pharmaceutical Company Limited among others.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. ADVANCED DRUG DELIVERY SYSTEMS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Advanced Drug Delivery Systems Market - By Delivery Type
3.2.2. Advanced Drug Delivery Systems Market - By Carrier Type
3.2.3. Advanced Drug Delivery Systems Market - By End User
3.2.4. Advanced Drug Delivery Systems Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS

4. ADVANCED DRUG DELIVERY SYSTEMS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. ADVANCED DRUG DELIVERY SYSTEMS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL ADVANCED DRUG DELIVERY SYSTEMS MARKET OVERVIEW
5.2. GLOBAL ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS

6. ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 - BY DELIVERY TYPE
6.1. OVERVIEW
6.2. DELIVERY TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. ORAL DRUG DELIVERY MARKET
6.3.1. Overview
6.3.2. Oral Drug Delivery Market Revenue Forecasts and Analysis (US$ Mn)
6.4. PULMONARY DRUG DELIVERY MARKET
6.4.1. Overview
6.4.2. Pulmonary Drug Delivery Market Revenue Forecasts and Analysis (US$ Mn)
6.5. TRANSDERMAL DRUG DELIVERY MARKET
6.5.1. Overview
6.5.2. Transdermal Drug Delivery Market Revenue Forecasts and Analysis (US$ Mn)
6.6. PARENTAL DRUG DELIVERY MARKET
6.6.1. Overview
6.6.2. Parental Drug Delivery Market Revenue Forecasts and Analysis (US$ Mn)

7. ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 - BY CARRIER TYPE
7.1. OVERVIEW
7.2. CARRIER TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. LIPOSOMES MARKET
7.3.1. Overview
7.3.2. Liposomes Market Revenue Forecasts and Analysis (US$ Mn)
7.4. NANOPARTICLES MARKET
7.4.1. Overview
7.4.2. Nanoparticles Market Revenue Forecasts and Analysis (US$ Mn)
7.5. MICROSPHERES MARKET
7.5.1. Overview
7.5.2. Microspheres Market Revenue Forecasts and Analysis (US$ Mn)
7.6. MONOCLONAL ANTIBODIES MARKET
7.6.1. Overview
7.6.2. Monoclonal Antibodies Market Revenue Forecasts and Analysis (US$ Mn)
7.7. OTHERS MARKET
7.7.1. Overview
7.7.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

8. ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. HOSPITALS MARKET
8.3.1. Overview
8.3.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
8.4. SPECIALIZED CLINICS MARKET
8.4.1. Overview
8.4.2. Specialized Clinics Market Revenue Forecasts and Analysis (US$ Mn)
8.5. OTHERS MARKET
8.5.1. Overview
8.5.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

9. NORTH AMERICA ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. NORTH AMERICA ADVANCED DRUG DELIVERY SYSTEMS MARKET OVERVIEW
9.2. NORTH AMERICA ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY DELIVERY TYPE (US$ MN)
9.4. NORTH AMERICA ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY CARRIER TYPE (US$ MN)
9.5. NORTH AMERICA ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.6. NORTH AMERICA ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.7. US MARKET OVERVIEW
9.7.1. US Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Delivery Type (US$ Mn)
9.7.2. US Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Carrier Type (US$ Mn)
9.7.3. US Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. CANADA MARKET OVERVIEW
9.8.1. Canada Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Delivery Type (US$ Mn)
9.8.2. Canada Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Carrier Type (US$ Mn)
9.8.3. Canada Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.9. MEXICO MARKET OVERVIEW
9.9.1. Mexico Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Delivery Type (US$ Mn)
9.9.2. Mexico Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Carrier Type (US$ Mn)
9.9.3. Mexico Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By End User (US$ Mn)

10. EUROPE ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. EUROPE ADVANCED DRUG DELIVERY SYSTEMS MARKET OVERVIEW
10.2. EUROPE ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY DELIVERY TYPE (US$ MN)
10.4. EUROPE ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY CARRIER TYPE (US$ MN)
10.5. EUROPE ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.6. EUROPE ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.7. UK MARKET OVERVIEW
10.7.1. UK Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Delivery Type (US$ Mn)
10.7.2. UK Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Carrier Type (US$ Mn)
10.7.3. UK Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. GERMANY MARKET OVERVIEW
10.8.1. Germany Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Delivery Type (US$ Mn)
10.8.2. Germany Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Carrier Type (US$ Mn)
10.8.3. Germany Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.9. FRANCE MARKET OVERVIEW
10.9.1. France Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Delivery Type (US$ Mn)
10.9.2. France Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Carrier Type (US$ Mn)
10.9.3. France Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By End User (US$ Mn)

11. ASIA PACIFIC ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC ADVANCED DRUG DELIVERY SYSTEMS MARKET OVERVIEW
11.2. ASIA PACIFIC ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY DELIVERY TYPE (US$ MN)
11.4. ASIA PACIFIC ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY CARRIER TYPE (US$ MN)
11.5. ASIA PACIFIC ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.6. ASIA PACIFIC ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.7. CHINA MARKET OVERVIEW
11.7.1. China Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Delivery Type (US$ Mn)
11.7.2. China Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Carrier Type (US$ Mn)
11.7.3. China Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. JAPAN MARKET OVERVIEW
11.8.1. Japan Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Delivery Type (US$ Mn)
11.8.2. Japan Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Carrier Type (US$ Mn)
11.8.3. Japan Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.9. INDIA MARKET OVERVIEW
11.9.1. India Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Delivery Type (US$ Mn)
11.9.2. India Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Carrier Type (US$ Mn)
11.9.3. India Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By End User (US$ Mn)

12. MIDDLE EAST AND AFRICA (MEA) ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA (MEA) ADVANCED DRUG DELIVERY SYSTEMS MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA (MEA) ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA (MEA) ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY DELIVERY TYPE (US$ MN)
12.4. MIDDLE EAST AND AFRICA (MEA) ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY CARRIER TYPE (US$ MN)
12.5. MIDDLE EAST AND AFRICA (MEA) ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.6. MIDDLE EAST AND AFRICA (MEA) ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.7. UAE MARKET OVERVIEW
12.7.1. UAE Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Delivery Type (US$ Mn)
12.7.2. UAE Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Carrier Type (US$ Mn)
12.7.3. UAE Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.8. SOUTH AFRICA MARKET OVERVIEW
12.8.1. South Africa Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Delivery Type (US$ Mn)
12.8.2. South Africa Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Carrier Type (US$ Mn)
12.8.3. South Africa Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.9. SAUDI ARABIA MARKET OVERVIEW
12.9.1. Saudi Arabia Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Delivery Type (US$ Mn)
12.9.2. Saudi Arabia Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Carrier Type (US$ Mn)
12.9.3. Saudi Arabia Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By End User (US$ Mn)

13. SOUTH AND CENTRAL AMERICA ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA ADVANCED DRUG DELIVERY SYSTEMS MARKET OVERVIEW
13.2. SOUTH AND CENTRAL AMERICA ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL AMERICA ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY DELIVERY TYPE (US$ MN)
13.4. SOUTH AND CENTRAL AMERICA ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY CARRIER TYPE (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.6. SOUTH AND CENTRAL AMERICA ADVANCED DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.7. BRAZIL MARKET OVERVIEW
13.7.1. Brazil Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Delivery Type (US$ Mn)
13.7.2. Brazil Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By Carrier Type (US$ Mn)
13.7.3. Brazil Advanced Drug Delivery Systems Market Revenue Forecasts and Analysis - By End User (US$ Mn)

14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions

15. ADVANCED DRUG DELIVERY SYSTEMS MARKET, KEY COMPANY PROFILES
15.1. JOHNSON & JOHNSON SERVICES, INC.
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. 3M
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. ABBOTT
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. BAXTER
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. ALLERGAN
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. ASTRAZENECA
15.6.1. Business Description
15.6.2. Financial Overview
15.6.3. Product Portfolio
15.6.4. SWOT Analysis
15.6.5. Key Developments
15.7. GENENTECH, INC.
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. NOVARTIS AG
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. PFIZER INC.
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. TAKEDA PHARMACEUTICAL COMPANY LIMITED
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. SWOT Analysis
15.10.6. Key Developments

16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
The List of Companies

1. Johnson & Johnson Services, Inc.
2. 3M
3. Abbott
4. Baxter
5. Allergan
6. AstraZeneca
7. Genentech, Inc.
8. Novartis AG
9. Pfizer, Inc.
10. Takeda Pharmaceutical Company Limited